MARKET

NSPR

NSPR

INSPIREMD
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6716
+0.0521
+8.41%
Opening 09:39 04/02 EDT
OPEN
0.6716
PREV CLOSE
0.6195
HIGH
0.6716
LOW
0.6716
VOLUME
1.47K
TURNOVER
--
52 WEEK HIGH
7.75
52 WEEK LOW
0.4800
MARKET CAP
2.91M
P/E (TTM)
-0.0927
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NSPR stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.

EPS

NSPR News

More
  • Edited Transcript of NSPR earnings conference call or presentation 10-Mar-20 12:30pm GMT
  • Thomson Reuters StreetEvents · 03/16 03:21
  • InspireMD, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
  • Simply Wall St. · 03/12 14:13
  • H.C. Wainwright Reiterates Buy on InspireMD, Lowers Price Target to $2
  • Benzinga · 03/11 12:11
  • InspireMD misses on revenue
  • seekingalpha · 03/10 17:06

Industry

Medical Equipment, Supplies & Distribution
-0.49%
Healthcare Equipment & Supplies
-0.37%

Hot Stocks

Symbol
Price
%Change

About NSPR

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
More

Webull offers kinds of InspireMD Inc stock information, including AMEX:NSPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPR stock news, and many more online research tools to help you make informed decisions.